# Angela Yee‐Moon Wang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/angela-yee-moon-wang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 30,129 |
| Field | Dialysis and Renal Disease Management |
| h-index | 85 |
| i10-index | 259 |
| Last Known Institution | Texas State University |
| OpenAlex ID | https://openalex.org/A5048145208 |
| ORCID iD | https://orcid.org/0000-0003-2508-7117 |
| Works | 514 |

## Researcher papers

Showing 12 of 18.

- [Chronic kidney disease: global dimension and perspectives](https://scholariq.org/papers/chronic-kidney-disease-global-dimension-and-perspectives/)
- [KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update](https://scholariq.org/papers/kdoqi-clinical-practice-guideline-for-nutrition-in-ckd-2020-update/)
- [Etiology of the Protein-Energy Wasting Syndrome in Chronic Kidney Disease: A Consensus Statement From the International Society of Renal Nutrition and Metabolism (ISRNM)](https://scholariq.org/papers/etiology-of-the-protein-energy-wasting-syndrome-in-chronic-kidney-disease-a/)
- [Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism](https://scholariq.org/papers/prevention-and-treatment-of-protein-energy-wasting-in-chronic-kidney-disease/)
- [Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/heart-failure-in-chronic-kidney-disease-conclusions-from-a-kidney-disease/)
- [Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/dialysis-initiation-modality-choice-access-and-prescription-conclusions-from-a/)
- [Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes](https://scholariq.org/papers/estimated-glomerular-filtration-rate-albuminuria-and-adverse-outcomes/)
- [International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis](https://scholariq.org/papers/international-society-for-peritoneal-dialysis-practice-recommendations/)
- [Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/chronic-kidney-disease-and-arrhythmias-conclusions-from-a-kidney-disease/)
- [Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey](https://scholariq.org/papers/status-of-care-for-end-stage-kidney-disease-in-countries-and-regions-worldwide/)
- [Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/management-and-treatment-of-glomerular-diseases-part-1-conclusions-from-a-kidney/)
- [Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/blood-pressure-and-volume-management-in-dialysis-conclusions-from-a-kidney/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)

## Researcher university

- [Texas State University](https://scholariq.org/institutions/texas-state-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.